Patrick R. Bergevin
Impact in
- Neurology top 10%
- CNS Lymphoma Diagnosis and Treatment
- Neuroblastoma Research and Treatments
-
- Glioma Diagnosis and Treatment
Papers in
- Oncology 5
- Cancer Treatment and Pharmacology 5
-
- Cancer therapeutics and mechanisms 2
- Plant-derived Lignans Synthesis and Bioactivity 1
- Co-authors
- Johannes Blom (3 shared papers)Fred R. Dick (1 shared paper)Ivan P. Law (1 shared paper)J. L. Ziegler (1 shared paper)M J O'Connell (1 shared paper)I T Magrath (1 shared paper)Vincent T. DeVita (1 shared paper)Peter H. Wiernik (1 shared paper)
- Journals
- Cancer (3 papers)Chemotherapy (1 paper)Medical Clinics of North America (1 paper)American Journal of Hospice and Palliative Medicine® (3 papers)Southern Medical Journal (1 paper)
- Partner nations
- United StatesUgandaSouth Africa
In The Last Decade
Patrick R. Bergevin
11 papers receiving 281 citations
Peers
Comparison fields: 5 of 61
- Neurology 115
- Genetics 66
- Pathology and Forensic Medicine 104
- Oncology 116
- Epidemiology 66
Countries citing papers authored by Patrick R. Bergevin
This map shows the geographic impact of Patrick R. Bergevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick R. Bergevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick R. Bergevin more than expected).
Fields of papers citing papers by Patrick R. Bergevin
This network shows the impact of papers produced by Patrick R. Bergevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick R. Bergevin. The network helps show where Patrick R. Bergevin may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick R. Bergevin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1974 | 138 | |
| 2 | 1975 | 107 | |
| 3 | 1980 | 56 | |
| 4 | Preliminary trials with a combination of adriamycin (NSC-123127) and bleomycin (NSC-125066) in adult malignancies. | 1974 | 8 |
| 5 | 1995 | 6 | |
| 6 | 1996 | 6 | |
| 7 | 1976 | 4 | |
| 8 | Guide to the use of cancer chemotherapeutic agents. | 1972 | 4 |
| 9 | 1978 | 3 | |
| 10 | 2005 | 2 | |
| 11 | 1995 | 1 | |
| 12 | 1976 | 0 |
About Patrick R. Bergevin
Patrick R. Bergevin is a scholar working on Oncology, Molecular Biology, Cardiology and Cardiovascular Medicine, Psychiatry and Mental health and Genetics, having authored 12 papers that have together received 335 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Lymphoma Diagnosis and Treatment (1 paper), Mechanical Circulatory Support Devices (1 paper), Intensive Care Unit Cognitive Disorders (1 paper), Chemotherapy-related skin toxicity (1 paper) and Plant-derived Lignans Synthesis and Bioactivity (1 paper). The work is most often cited by research in Neurology (115 citations), Genetics (66 citations), Pathology and Forensic Medicine (104 citations), Oncology (116 citations) and Epidemiology (66 citations). Patrick R. Bergevin has collaborated with scholars based in United States, Uganda and South Africa. Frequent co-authors include Johannes Blom, Fred R. Dick, Ivan P. Law, J. L. Ziegler, M J O'Connell, I T Magrath, Vincent T. DeVita, Peter H. Wiernik, P. Schein and S M Hubbard. Their work appears in journals such as Cancer, Chemotherapy, Medical Clinics of North America, American Journal of Hospice and Palliative Medicine® and Southern Medical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.